Cargando…
Expression of Concern: Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377627/ https://www.ncbi.nlm.nih.gov/pubmed/37509332 http://dx.doi.org/10.3390/cancers15143668 |
_version_ | 1785079564443058176 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10377627 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103776272023-07-29 Expression of Concern: Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774 Cancers (Basel) Expression of Concern MDPI 2023-07-19 /pmc/articles/PMC10377627/ /pubmed/37509332 http://dx.doi.org/10.3390/cancers15143668 Text en © 2023 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Expression of Concern Expression of Concern: Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774 |
title | Expression of Concern: Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774 |
title_full | Expression of Concern: Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774 |
title_fullStr | Expression of Concern: Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774 |
title_full_unstemmed | Expression of Concern: Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774 |
title_short | Expression of Concern: Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774 |
title_sort | expression of concern: barańska, a.; kanadys, w. oral contraceptive use and breast cancer risk for brca1 and brca2 mutation carriers: systematic review and meta-analysis of case–control studies. cancers 2022, 14, 4774 |
topic | Expression of Concern |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377627/ https://www.ncbi.nlm.nih.gov/pubmed/37509332 http://dx.doi.org/10.3390/cancers15143668 |
work_keys_str_mv | AT expressionofconcernbaranskaakanadysworalcontraceptiveuseandbreastcancerriskforbrca1andbrca2mutationcarrierssystematicreviewandmetaanalysisofcasecontrolstudiescancers2022144774 |